First-line use of cabazitaxel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm study in comparison with docetaxel.
Stephane Oudard
Honoraria - Bayer; Novartis; Roche; Sanofi
Lisa Sengelov
Honoraria - Sanofi
Paul N. Mainwaring
Consultant or Advisory Role - Consultant
Honoraria - HONORARIA
Antoine Thiery- Vuillemin
Honoraria - Sanofi
Expert Testimony - Sanofi
Christine Theodore
No relevant relationships to disclose
Evgeny Kulikov
No relevant relationships to disclose
Jeffrey Yachnin
Consultant or Advisory Role - Sanofi
Other Remuneration - Other
Ivo Kocak
No relevant relationships to disclose
Vesa V Kataja
Consultant or Advisory Role - advisory board
Marjaana Luukkaa
Consultant or Advisory Role - Janssen Pharmaceutical ; Sanofi
Honoraria - Sanofi
Other Remuneration - Amgen; GlaxoSmithKline; Merck; Roche; Sanofi
Aleander Nosov
No relevant relationships to disclose
Marie Hjelm-Eriksson
No relevant relationships to disclose
Jeffrey Bubis
No relevant relationships to disclose
Liji Shen
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Marie-Laure Risse
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
A. Oliver Sartor
Consultant or Advisory Role - Sanofi ; Sanofi
Honoraria - Sanofi ; Sanofi